A pharmacodynamic study of the optimal P2Y(12) inhibitor regimen for East Asian patients with acute coronary syndrome

BACKGROUND/AIMS: Newer P2Y(12) inhibitors, such as prasugrel and ticagrelor, have greater antiplatelet efficacy but may increase the risk of bleeding. In this study, we compared the pharmacodynamic efficacy of prasugrel and ticagrelor in East Asian patients with acute coronary syndrome (ACS). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Hyun, Ahn, Sung Gyun, Park, Bonil, Park, Sang Wook, Kang, Yong Seok, Lee, Jun-Won, Youn, Young Jin, Ahn, Min-Soo, Kim, Jang-Young, Yoo, Byung-Su, Lee, Seung-Hwan, Yoon, Junghan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578016/
https://www.ncbi.nlm.nih.gov/pubmed/26354056
http://dx.doi.org/10.3904/kjim.2015.30.5.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578016/
https://www.ncbi.nlm.nih.gov/pubmed/26354056
http://dx.doi.org/10.3904/kjim.2015.30.5.620

Ejemplares similares